The Centers for Disease Control and Prevention (CDC) has updated and clarified its COVID-19 booster guidance, unequivocally recommending that everyone 12 years old and above receive a booster dose if eligible.
Below is a summary of the updated guidance:
- Individuals 12-17 years old are recommended to receive a booster shot 5 months after completion of their initial Pfizer-BioNTech (Pfizer) vaccination series. At this time, only the Pfizer vaccine is authorized for ages 12-17.
- All individuals ages 12 and older are recommended to receive a Pfizer dose 5 months after completing the initial series instead of the previously recommended 6 months. The booster interval for people who initially received the Johnson & Johnson vaccine (2 months) or the Moderna vaccine (6 months) has not changed.
- Moderately or severely immunocompromised children ages 5-11 are recommended to receive an additional primary (or third) dose of vaccine 28 days after completing their second initial series vaccination. At this time, only the Pfizer vaccine is authorized for ages 5-11.